IRF7 and atherosclerosis: Understanding how these genes regulate SMC-to-MAC transitions may reveal new mechanisms of SMC plasticity and vascular inflammation, highlighting FHOD1 and IRF7 as potential therapeutic targets to mitigate vascular remodeling and atherosclerosis progression.